Information  X 
Enter a valid email address

Company Name matching 'Junshi Biosciences'

Date
Time Source
Company
Announcement
17 Sep 2020 11:00 pm GNW   Junshi Biosciences Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab for the Treatment of Soft Tissue Sarcoma
16 Sep 2020 5:45 pm GNW   Junshi Biosciences Junshi Biosciences and Wigen Biomedicine Enter Global Development and Commercialization Collaboration for Four Small Molecule Cancer Drug Candidates
11 Sep 2020 1:36 am GNW   Junshi Biosciences Junshi Biosciences Receives FDA Breakthrough Therapy Designation for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
31 Aug 2020 1:00 am GNW   Junshi Biosciences Junshi Biosciences Announces Financial Results for Six Months Ended June 30, 2020 and Provides Corporate Updates
20 Aug 2020 3:45 pm GNW   Junshi Biosciences Junshi Biosciences and Impact Therapeutics Establish Joint Venture to Develop PARP Inhibitor Senaparib (IMP4297) in China
10 Aug 2020 3:07 am GNW   Junshi Biosciences TopAlliance Appoints Patricia Keegan, M.D., as Chief Medical Officer
13 Jul 2020 1:00 am GNW   Junshi Biosciences Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016 in China
12 Jul 2020 1:20 pm GNW   Junshi Biosciences Junshi Biosciences Announces Approval of “B” Marker Removal from Company’s Stock Name by HKEX
04 May 2020 2:14 pm GNW   Junshi Biosciences Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19
30 Apr 2020 3:56 pm GNW   Junshi Biosciences Junshi Biosciences Announces Acceptance of a Supplemental NDA in China for Toripalimab in Advanced Nasopharyngeal Carcinoma
30 Mar 2020 5:43 pm GNW   Junshi Biosciences Junshi Biosciences Announces Full-Year 2019 Financial Results and Business Updates
  5:30 pm GNW   Junshi Biosciences Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab in Combination with Pfizer’s Axitinib for the Treatment of Mucosal Melanoma
20 Mar 2020 4:15 pm GNW   Junshi Biosciences Junshi Biosciences Announces Co-Development Agreement with IMCAS to Advance Neutralizing Antibodies as Potential Novel Treatment for COVID-19
02 Mar 2020 7:20 pm GNW   Junshi Biosciences Junshi Biosciences Reports Key 2019 Financial Results


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t